Table of Contents
Psychopharmacology during Pregnancy Addressing Clinical Need through Science
FDA: December 4, 2000
Mental Health is Fundamental to All Health David Satcher, M.D., Ph.D.
Illness Model: Major Depression
Risk-Benefit Decision-Making: A Framework
PPT Slide
Decision-Making Framework is Stable
Available Prospective Data for Application to Model
Intrauterine Fetal Death
Morphologic Teratogenicity
Growth Impairment
Behavioral Teratogenicity
Neonatal Toxicity
The Treatment Dilemma
The Clinician’s Dilemma: Morphologic Teratogenicity
The Clinician’s Dilemma: Growth Impairment
The Clinician’s Dilemma: Behavioral Teratogenicity
The Clinician’s Dilemma: Dosing
PPT Slide
PPT Slide
Pharmacotherapy
PPT Slide
The Researcher’s Dilemma: What is Being Measured?
The Researcher’s Dilemma: Randomized Controlled Trials
WARNING! Insufficient Medical Research Can be Hazardous to your Health C. Everett Koop, M.D.
NIMH R01 60335 Antidepressant Use during Pregnancy
Study Groups
Hypotheses
Hypotheses
Hypotheses
Hypotheses
PPT Slide
Conclusion Sufficient Medical Research will Improve your Health |
